Imaging of Thoracic Malignancies

  • Sumer N. Shikhare


Bronchogenic carcinoma remains the most common cause of cancer death worldwide with an estimated 155,870 deaths in 2017, which is approximately 26% of all cancer deaths in the United States. Lung cancer is also the most common non-skin cancer affecting both men and women, accounting for an estimated 222,500 new cases in 2017. Since a large proportion of cases with lung cancer get diagnosed at an advanced-stage, the overall 5-year relative survival rate is low—17% for men and 24% for women. The increased incidence of bronchogenic cancer is attributed to cigarette smoking [1, 2]. Cigarette smoking is a risk factor for all types of lung cancer.


  1. 1.
    American Cancer Society. Cancer prevention & early detection facts & figures 2017–2018. Atlanta: American Cancer Society; 2017.Google Scholar
  2. 2.
    Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW, Wender RC. Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2017;67(2):100–21.PubMedCrossRefGoogle Scholar
  3. 3.
    Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB, Geisinger K, Hirsch FR, Ishikawa Y, Kerr KM, Noguchi M, Pelosi G, Powell CA, Tsao MS, Wistuba I, WHO Panel. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–60.PubMedCrossRefGoogle Scholar
  4. 4.
    Padley SPG, Lazoura O. Pulmonary neoplasms. In: Adam A, Dixon AK, Gillard JH, Schaefer-Prokop CM, editors. Grainger & Allison’s diagnostic radiology: a textbook of medical imaging. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2015.Google Scholar
  5. 5.
    Hansell D, et al. Neoplasms of the lungs. Airways, and pleura. In: Lynch D, editor. Imaging of diseases of the chest. 5th ed. New York: Elsivier; 2010. p. 787–879.CrossRefGoogle Scholar
  6. 6.
    Yang P, Cerhan J, Vierkant R, et al. Adenocarcinoma of the lung is strongly associated with cigarette smoking: further evidence from a prospective study of women. Am J Epidemiol. 2002;156(12):1114–22.PubMedCrossRefGoogle Scholar
  7. 7.
    Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiol Clin N Am. 2012;50(5):863–76.PubMedCrossRefGoogle Scholar
  8. 8.
    WR Webb. “Lung cancer and bronchopulmonary neoplasm.” In: Thoracic imaging pulmonary and cardiovascular radiology, 2nd edn., Wolters Kluver, Alphen aan den Rijn, 2011, pp. 69–116.Google Scholar
  9. 9.
    Khuder SA, Mutgi AB. Effect of smoking cessation on major histologic types of lung cancer. Chest. 2001;120(5):1577–83.PubMedCrossRefGoogle Scholar
  10. 10.
    Öberg M, Jaakkola MS, Woodward A, et al. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377(9760):139–46.PubMedCrossRefGoogle Scholar
  11. 11.
    Cruz D, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011;32(4):605–44.CrossRefGoogle Scholar
  12. 12.
    Hoffmann D, Djordjevic MV, Hoffmann I. The changing cigarette. Prev Med. 1997;26(4):427–34.PubMedCrossRefGoogle Scholar
  13. 13.
    MacMahon H, Naidich DP, Goo JM, Lee KS, Leung ANC, Mayo JR, Mehta AC, Ohno Y, Powell CA, Prokop M, Rubin GD, Schaefer-Prokop CM, Travis WD, Van Schil PE, Bankier AA. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology. 2017;284(1):228–43.PubMedCrossRefGoogle Scholar
  14. 14.
    Snoeckx A, Reyntiens P, Desbuquoit D, Spinhoven MJ, Van Schil PE, van Meerbeeck JP, Parizel PM. Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology. Insights Imaging. 2018;9(1):73–86.PubMedCrossRefGoogle Scholar
  15. 15.
    McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013;369(10):910–9.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007;242(2):555–62.PubMedCrossRefGoogle Scholar
  17. 17.
    Horeweg N, van der Aalst CM, Thunnissen E, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med. 2013;187(8):848–54.PubMedCrossRefGoogle Scholar
  18. 18.
    Hyodo T, Kanazawa S, Dendo S, et al. Intrapulmonary lymph nodes: thin-section CT findings, pathological findings, and CT differential diagnosis from pulmonary metastatic nodules. Acta Med Okayama. 2004;58(5):235–40.PubMedGoogle Scholar
  19. 19.
    Edey AJ, Hansell DM. Incidentally detected small pulmonary nodules on CT. Clin Radiol. 2009;64(9):872–84.PubMedCrossRefGoogle Scholar
  20. 20.
    Ahn MI, Gleeson TG, Chan IH, et al. Perifissural nodules seen at CT screening for lung cancer. Radiology. 2010;254:949–56.PubMedCrossRefGoogle Scholar
  21. 21.
    Woodring JH, Fried AM. Significance of wall thickness in solitary cavities of the lung: a follow-up study. Am J Roentgenol. 1983;140(3):473–4.CrossRefGoogle Scholar
  22. 22.
    Truong MT, Ko JP, Rossi SE, Rossi I, Viswanathan C, Bruzzi JF, Marom EM, Erasmus JJ. Update in the evaluation of the solitary pulmonary nodule. Radiographics. 2014;34(6):1658–79.PubMedCrossRefGoogle Scholar
  23. 23.
    Winer-Muram HT. The solitary pulmonary nodule. Radiology. 2006;239(1):34–49.PubMedCrossRefGoogle Scholar
  24. 24.
    Pinto PS. The CT halo sign. Radiology. 2004;230(1):109–10.PubMedCrossRefGoogle Scholar
  25. 25.
    Kim SJ, Lee KS, Ryu YH, et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. AJR Am J Roentgenol. 2003;180(5):1251–4.PubMedCrossRefGoogle Scholar
  26. 26.
    Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology. 2013;266(1):304–17.PubMedCrossRefGoogle Scholar
  27. 27.
    Lee HY, Lee KS. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. J Thorac Imaging. 2011;26(2):106–18.PubMedCrossRefGoogle Scholar
  28. 28.
    Kim HY, Shim YM, Lee KS, Han J, Yi CA, Kim YK. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology. 2007;245(1):267–75.PubMedCrossRefGoogle Scholar
  29. 29.
    Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–85.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013;137(5):685–705.PubMedCrossRefGoogle Scholar
  31. 31.
    Li F, Sone S, Abe H, Macmahon H, Doi K. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology. 2004;233(3):793–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma executive summary. Proc Am Thorac Soc. 2011;8(5):381–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol. 2000;73(876):1252–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Swensen SJ, Brown LR, Colby TV, et al. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology. 1995;194:393–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Swensen SJ, Brown LR, Colby TV, et al. Lung nodule enhancement at CT: prospective findings. Radiology. 1996;201:447–55.PubMedCrossRefGoogle Scholar
  36. 36.
    Saita S, Tanzillo A, Riscica C, et al. Bronchial brushing and biopsy: a comparative evaluation in diagnosing visible bronchial lesions. Eur J Cardiothorac Surg. 1990;4:270–2.PubMedCrossRefGoogle Scholar
  37. 37.
    Ho CC, Lin CK, Yang CY, Chang LY, Lin SY, Yu CJ. Current advances of endobronchial ultrasonography in the diagnosis and staging of lung cancer. J Thorac Dis. 2016;8(Suppl 9):S690–6.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Patil SS, Godoy MC, Sorensen JI, Marom EM. Lung cancer imaging. Semin Diagn Pathol. 2014;31(4):293–305.PubMedCrossRefGoogle Scholar
  39. 39.
    Hubner KF, Buonocore E, Gould HR, et al. Differentiating benign from malignant lung lesions using “quantitative” parameters of FDG PET images. Clin Nucl Med. 1996;21(12):941–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med. 1996;37(6):943–8.PubMedGoogle Scholar
  41. 41.
    MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005;237:395–400.PubMedCrossRefGoogle Scholar
  42. 42.
    Takashima S, Sone S, Li F, et al. Small solitary pulmonary nodules (< or = 1 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. AJR Am J Roentgenol. 2003;180:955–64.PubMedCrossRefGoogle Scholar
  43. 43.
    Klein JS, Braff S. Imaging evaluation of the solitary pulmonary nodule. Clin Chest Med. 2008;29:15–38.PubMedCrossRefGoogle Scholar
  44. 44.
    Rubens MB, et al. Tumours of the lung. In: Textbook of radiology and imaging, vol. vol 1. 7th ed. London: Churchill Livingstone; 2003. p. 107–30.Google Scholar
  45. 45.
    Woodring JH, Fried AM, Chuang VP. Solitary cavities of the lung: diagnostic implications of cavity wall thickness. AJR Am J Roentgenol. 1980;135:1269–71.PubMedCrossRefGoogle Scholar
  46. 46.
    Chou SH, Kicska G, Kanne JP, Pipavath S. Cheerio sign. J Thorac Imaging. 2013;28(1):W4.PubMedCrossRefGoogle Scholar
  47. 47.
    Lee KS, Kim Y, Han J, et al. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. Radiographics. 1997;17(6):1345–57.PubMedCrossRefGoogle Scholar
  48. 48.
    Grewal RG, Austin JH. CT demonstration of calcification in carcinoma of the lung. J Comput Assist Tomogr. 1994;18:867–71.PubMedCrossRefGoogle Scholar
  49. 49.
    Gilbert C, Yarmus L, Feller-Kopman D. Use of endobronchial ultrasound and endoscopic ultrasound to stage the mediastinum in early-stage lung cancer. J Natl Compr Cancer Netw. 2012;10(10):1277–82.CrossRefGoogle Scholar
  50. 50.
    Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231(2):305–32.PubMedCrossRefGoogle Scholar
  51. 51.
    Dougherty B, Jersmann HP, Robinson PC, Nguyen P. Staging the mediastinum: what is current best practice? Lung Cancer Manag. 2013;2(2):153–62.CrossRefGoogle Scholar
  52. 52.
    Caulo A, Mirsadraee S, Maggi F, et al. Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria. Eur Radiol. 2012;22(3):588–606.PubMedCrossRefGoogle Scholar
  53. 53.
    Glazer H, Kaiser L, Anderson D, et al. Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology. 1989;173(1):37–42.PubMedCrossRefGoogle Scholar
  54. 54.
    Allen MS, Mathisen DJ, Grillo HC, et al. Bronchogenic carcinoma with chest wall invasion. Ann Thorac Surg. 1991;51(6):948–51.PubMedCrossRefGoogle Scholar
  55. 55.
    Cangemi V, Volpino P, D’Andrea N, et al. Results of surgical treatment of stage IIIA non-small cell lung cancer. Eur J Cardiothorac Surg. 1995;9:352–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Ratto G, Piacenza G, Frola C, et al. Chest wall involvement by lung cancer: computed tomographic detection and results of operation. Ann Thorac Surg. 1991;51(2):182–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Pauls S, Schmidt SA, Juchems MS, et al. Diffusion-weighted MR imaging in comparison to integrated [18F]-FDG PET/CT for N-staging in patients with lung cancer. Eur J Radiol. 2012;81(1):178–82.PubMedCrossRefGoogle Scholar
  58. 58.
    Hendifar AE, Marchevsky AM, Tuli R. Neuroendocrine tumors of the lung: current challenges and advances in the diagnosis and management of well-differentiated disease. J Thorac Oncol. 2017;12(3):425–36.PubMedCrossRefGoogle Scholar
  59. 59.
    Dincer HE, Podgaetz E, Andrade RS. Pulmonary neuroendocrine tumors: part I. Spectrum and characteristics of tumors. J Bronchol Interv Pulmonol. 2015;22(3):267–73.Google Scholar
  60. 60.
    Lee D, Rho JY, Kang S, Yoo KJ, Choi HJ. CT findings of small cell lung carcinoma: can recognizable features be found? Medicine (Baltimore). 2016;95(47):e5426.CrossRefGoogle Scholar
  61. 61.
    Carter BW, Glisson BS, Truong MT, Erasmus JJ. Small cell lung carcinoma: staging, imaging, and treatment considerations. Radiographics. 2014;34(6):1707–21.PubMedCrossRefGoogle Scholar
  62. 62.
    Kruger S, Buck AK, Blumstein NM, et al. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours. J Intern Med. 2006;260:545–50.PubMedCrossRefGoogle Scholar
  63. 63.
    Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017;151(1):193–203.PubMedCrossRefGoogle Scholar
  64. 64.
    Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):138–55.PubMedCrossRefGoogle Scholar
  65. 65.
    Au V, Leung AN. Radiologic manifestations of lymphoma in the thorax. Am J Roentgenol. 1997;168(1):93–8.CrossRefGoogle Scholar
  66. 66.
    Lewis ER, Caskey CI, Fishman EK. Lymphoma of the lung: CT findings in 31 patients. AJR Am J Roentgenol. 1991;156:711–4.PubMedCrossRefGoogle Scholar
  67. 67.
    Lee KS, Kim Y, Primack SL. Imaging of pulmonary lymphomas. Am J Roentgenol. 1997;168(2):339–45.CrossRefGoogle Scholar
  68. 68.
    Ferraro P, Trastek VF, Adlakha H, et al. Primary non-Hodgkin’s lymphoma of the lung. Ann Thorac Surg. 2000;69:993–7.PubMedCrossRefGoogle Scholar
  69. 69.
    King LJ, Padley SP, Wotherspoon AC, et al. Pulmonary MALT lymphoma: imaging findings in 24 cases. Eur Radiol. 2000;10:1932–8.PubMedCrossRefGoogle Scholar
  70. 70.
    McCulloch GL, Sinnatamby R, Stewart S, et al. High-resolution computed tomographic appearance of MALToma of the lung. Eur Radiol. 1998;8:1669–73.PubMedCrossRefGoogle Scholar
  71. 71.
    Foran P, Colleran G, Madewell J, O’Sullivan PJ. Imaging of thoracic sarcomas of the chest wall, pleura, and lung. Semin Ultrasound CT MR. 2011;32(5):365–76.PubMedCrossRefGoogle Scholar
  72. 72.
    Desmarais P, Laskine M, Caporuscio C. Primary pulmonary artery angiosarcoma mimicking pulmonary embolism in a 66-year-old man with dyspnea. CMAJ. 2016;188(17–18):E509–12.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Naidich D, Tarras M, Garay S, et al. Kaposi’s sarcoma. CT-radiographic correlation. Chest. 1989;96(4):723–8.PubMedCrossRefGoogle Scholar
  74. 74.
    Coppage L, Shaw C, Curtis AM. Metastatic disease to the chest in patients with extrathoracic malignancy. J Thorac Imaging. 1987;2(4):24–37.PubMedCrossRefGoogle Scholar
  75. 75.
    Seo JB, Im J-G, Goo JM, Chung MJ, Kim M-Y. Atypical pulmonary metastases: spectrum of radiologic findings. Radiographics. 2001;21(2):403–17.PubMedCrossRefGoogle Scholar
  76. 76.
    Ikezoe J, Godwin JD, Hunt KJ, Marglin SI. Pulmonary lymphangitic carcinomatosis: chronicity of radiographic findings in long-term survivors. AJR Am J Roentgenol. 1995;165(1):49–52.PubMedCrossRefGoogle Scholar
  77. 77.
    Johkoh T, Ikezoe J, Tomiyama N, Nagareda T, Kohno N, Takeuchi N, Yamagami H, Kido S, Takashima S, Arisawa J, et al. CT findings in lymphangitic carcinomatosis of the lung: correlation with histologic findings and pulmonary function tests. AJR Am J Roentgenol. 1992;158(6):1217–22.PubMedCrossRefGoogle Scholar
  78. 78.
    Thomas A, Lenox R. Pulmonary lymphangitic carcinomatosis as a primary manifestation of colon cancer in a young adult. CMAJ. 2008;179(4):338–40.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Furuya K, Yasumori K, Takeo S, Sakino I, Uesugi N, Momosaki S, Muranaka T. Lung CT: part 1, Mimickers of lung cancer – spectrum of CT findings with pathologic correlation. AJR Am J Roentgenol. 2012;199(4):W454–63.PubMedCrossRefGoogle Scholar
  80. 80.
    Siegelman S, Khouri N, Scott W, et al. Pulmonary hamartoma: CT findings. Radiology. 1986;160(2):313–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Sumer N. Shikhare
    • 1
  1. 1.Department of Diagnostic RadiologyKhoo Teck Puat HospitalSingaporeSingapore

Personalised recommendations